---
category: news
title: "insitro raises $400M for machine learning-powered drug discovery efforts"
excerpt: "The artificial intelligence-powered drug discovery company insitro has secured a mammoth funding round of $400 million, to carry forward its development efforts and Big Pharma partnerships with the likes of Gilead and Bristol Myers Squibb."
publishedDateTime: 2021-03-15T15:14:00Z
originalUrl: "https://www.fiercebiotech.com/medtech/insitro-raises-400m-for-machine-learning-powered-drug-discovery-efforts"
webUrl: "https://www.fiercebiotech.com/medtech/insitro-raises-400m-for-machine-learning-powered-drug-discovery-efforts"
type: article
quality: 53
heat: -1
published: false

provider:
  name: FierceBiotech
  domain: fiercebiotech.com

topics:
  - Machine Learning
  - AI

images:
  - url: "https://qtxasset.com/fiercebiotech/1615816901/molecule.jpg/molecule.jpg?oUmdMDlHnkNKQEtqtycHfXAUxU2F_06Y"
    width: 740
    height: 442
    isCached: true

related:
  - title: "Insitro raises $400m for machine learning drug discovery push"
    excerpt: "A machine learning start-up that is aiming to speed up drug discovery and shake up the pharmaceutical industry has raised $400m from investors including SoftBank and Temasek. Insitro, which is run by former Stanford artificial intelligence professor ..."
    publishedDateTime: 2021-03-15T05:00:00Z
    webUrl: "https://www.ft.com/content/9a63dbe9-a79a-4cc4-bd34-5b492e2d5305"
    ampWebUrl: "https://amp.ft.com/content/9a63dbe9-a79a-4cc4-bd34-5b492e2d5305"
    cdnAmpWebUrl: "https://amp-ft-com.cdn.ampproject.org/c/s/amp.ft.com/content/9a63dbe9-a79a-4cc4-bd34-5b492e2d5305"
    type: article
    provider:
      name: The Financial Times
      domain: ft.com
    quality: 74
    images:
      - url: "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F651880f5-5d04-4007-b936-6310d36b2917.jpg?source=google-amp&fit=scale-down&width=500"
        width: 500
        height: 281
        isCached: true

secured: "Q35jlhxXw7iOEsl48deUgHt+beNJ3/RdJmrs69wFhB63LoNCUjQDtm7k4dOgYGxBbzEAcKJ2Hr/ayQIIn8FjUzFvxeGkKS87DK44CRq6awUbXMufqeGgB2eAD16wBv7UQ+ZykyM0xeIfIN1zkQmzNIKm5mgnlxmiLPtBxDFy5hg9TKh7hEpMd1QFJTonnCsz0OS3hqH5tbNhQ41pnjDk7puVmH99xT7g/cker2vFuc3If6VmpEVAScsUWm+VJJfMlYeuRQqHTpF48JaM5iQPAbyx4M+lz5zcmCmM2OIzm4ABlvgjjC6qHsdr+ux3WacefcVrlztA/S8K1EJeIcgE383v5Fm4TnAxNNoK58k6Tpg=;H6n3jtoOicYA0WLv5vUKXA=="
---

